SCHEMBL3366828

SCHEMBL3366828

CC(Cl)C#CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3157295 0.72
SCHEMBL152657 0.69
SCHEMBL181215 0.67
SCHEMBL6549803 0.67
SCHEMBL20483651 0.67
SCHEMBL6800593 0.67
SCHEMBL1110075 0.67
SCHEMBL7637610 0.67
SCHEMBL7637607 0.67
SCHEMBL1110016 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431195-B1 Tire and method for making a tire or tire component GOODYEAR TIRE & RUBBER (US) 2014-07-30 EP claimed
EP-4622958-A1 SYNTHESIS OF PYRROLO[3,4-C]PYRROLES Novo Nordisk Health Care AG (CH) 2025-10-01 EP disclosed
WO-2024112764-A1 SYNTHESIS OF PYRROLO[3,4-C]PYRROLES NOVO NORDISK HEALTH CARE AG (CH) 2024-05-30 WO disclosed
US-20200276146-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC 2020-09-03 US disclosed
US-10610507-B2 Methods for the treatment of sialorrhea NeuRx Pharmaceuticals LLC (US) 2020-04-07 US disclosed
US-20190015371-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC 2019-01-17 US disclosed
US-10131610-B2 Methods of producing dicarbonyl compounds EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2018-11-20 US disclosed
US-20170281585-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC (US) 2017-10-05 US disclosed
US-20160257638-A1 METHODS OF PRODUCING DICARBONYL COMPOUNDS EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2016-09-08 US disclosed
US-20160151321-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC 2016-06-02 US disclosed
US-20010031787-A1 Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers TECHNOLOGY RECOVERY SYSTEMS, LLC 2001-10-18 US disclosed
WO-2001043775-A2 HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS DERMATRENDS, INC. (US) 2001-06-21 WO disclosed
US-6203724-B1 FOR LIQUD CRYSTAL DISPLAYS, OPTICAL SWITCHES, OPTICAL FILTERS, ELECTRO-OPTICAL DISPLAY ELEMENT MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2001-03-20 US disclosed
US-6123961-A WITHOUT CARDIOVASCULAR DEPRESSING ACTIVITY SIDE EFFECT, BY ADMINISTERING R(-)-4-DIETHYLAMINO-2-BUTYNYL CYCLOHEXYLPHENYLGLYCOLATE OR SALT, FREE OF ITS CORRESPONDING S-ENANTIOMER BRIDGE PHARMA, INC. (US) 2000-09-26 US disclosed
EP-0433267-B1 Process for preparing eicosatetraynoic acid CIRD GALDERMA (FR) 1994-09-21 EP disclosed
EP-0279954-B1 AMIDES OF EICOSATETRAYNOIC ACID, THEIR PHARMACEUTICAL AND COSMETIC USE, THEIR PREPARATION AND PROCESS FOR THE PREPARATION OF EICOSATETRAYNOIC ACID CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) 1993-03-17 EP disclosed
EP-0433267-A2 Process for preparing eicosatetraynoic acid CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA Groupement d'Intérêt Economique dit: (FR) 1991-06-19 EP disclosed
US-4916136-A LIPOXYGENASE AND CYCLOOXYGENASE INHIBITORS Centre International de Recherches Dermatologioues C.I.R.D. (FR) 1990-04-10 US disclosed
EP-0279954-A2 Amides of eicosatetraynoic acid, their pharmaceutical and cosmetic use, their preparation and process for the preparation of eicosatetraynoic acid CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) 1988-08-31 EP disclosed
US-3982894-A Method of inhibiting acidic corrosion of ferrous metals with polyquaternary amino polymers PETROLITE CORPORATION (US) 1976-09-28 US disclosed